Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patients

  • 📰 Reuters
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

The FDA approved Gilead’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the U.S. $GILD

- The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States.

Remdesivir has been available under an FDA emergency use authorization since May, after a study led by the National Institutes of Health showed it reduced hospital stays by five days. Remdesivir, which will be sold under the brand name Veklury, costs $3,120 for a five-day treatment course, or $2,340 for government purchasers such as the Department of Veterans Affairs. Shares of Gilead rose 4.3% in after hours trading to $63.30.Remdesivir has become the standard of care for patients hospitalized with severe COVID-19 even though it has not been shown to improve survival.

The company said Veklury has regulatory approvals or temporary authorizations in about 50 additional countries.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

The Solidarity Trial showed it did not reduce deaths: But it might help less sick people recover a little bit faster:

Don't worry. You cannot afford it.

Of course it's approved after Trump advertised it a couple of weeks ago. It was the ultimate in product placement. Must be a few people with shares in the company.

Great news. As the real story is that it will save lives. Despite the Trump haters who would prefer more deaths than to congratulate Trump.

This is a political stunt to boost Trump popularity -- it is a single 'achievement' that he will use as his COVID19 pandemic response 'success'. Nothing prohibited to continue testing remdesivir before approving it. It remains to be seen how effective this treatment is.

Gilead was a mountainous region east of the Jordan River, situated in modern-day Jordan. It is also referred to by the Aramaic name Yegar-Sahadutha, which carries the same meaning as the Hebrew Gilead, namely 'heap [of stones] of testimony' Pharmafia

I thought medical journal just came out with a study that said the drug doesn't do much at all to help Covid patients unless it's taken at a specific time of disease?

Good because the final study announced this week shows that it reduces recovery time and death rates.

Keep your poisons

WHO shows the result is not helpful at all, why FDA approved it?

It saved my Dad.

Interesting. I'd like to see results from the trials first.

'Remdesivir, which will be sold under the brand name Veklury, costs $3,120 for a five-day treatment course, or $2,340 for government purchasers such as the Department of Veterans Affairs. Shares of Gilead rose 4.3% in after hours trading to $63.30. ' covid19

I thought huge studies showed it doesn't work

🧐?

Marketing ✅

I assume trump has shares

WHO has lost its track, is now just a failed body and an institutional liability.

So it untested and fast track. Their not releasing any studies and WHO said testing has seen no effect on COVID

But is still investigated ? and we heard that before ...

And it doesn't work...

There is a massacre going on in River State oyigbo They are moving from house to house slaughtering people oyigbokillings NIGERIABLEEDS

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA extends Covid-19 vaccine meeting to allow public inputThe FDA has added extra time to a daylong meeting Thursday of its vaccine advisers. The meeting will now include at least an hour and a half for public input, according to an agenda posted online. 2000: Vaccine skepticism is cool. 2010: Vaccine skepticism is anti-science. 2020: Vaccine skepticism is woke. Amazing to see the battle between big pharma creating the narrative of 'anti-vaxxers' being anti-science and Democrats claiming to be for science but anti-covid vaccine. Whatever they added are useless, America had a crazy selfish president, you just need to remove this Donald Trump, guaranteed America back to normal.
Source: CNN - 🏆 4. / 95 Read more »

FDA approves first COVID-19 drug: antiviral remdesivirA large study found the medicine, given to hospitalized patients through an IV, cut the time to recovery by five days.
Source: latimes - 🏆 11. / 82 Read more »

FDA Approves Remdesivir For Covid-19 TreatmentThe drug was previously granted emergency use authorization, not full approval. It ain’t even gonna work How to end the COVID-19 pandemic StopCovid GreatLockdown SirEmmanuel12 ifb
Source: Forbes - 🏆 394. / 53 Read more »

Gilead's remdesivir gets U.S. FDA approval for use in hospitalized COVID-19 patientsGilead said it is currently meeting real-time demand for remdesivir, which is sold under the brand name Veklury, in the United States and anticipates meeting global demand by the end of October. Remdesivir, previously granted emergency use authorization by the FDA for COVID-19, was one of the drugs Didn’t I read a week ago it wasn’t effective?
Source: YahooNews - 🏆 380. / 59 Read more »

FDA approves remdesivir to treat Covid-19The US Food and Drug Administration has approved remdesivir for the treatment of coronavirus infection, according to the drug's maker, Gilead Sciences Last week it wasn't effective. Now it is? C'mon FDA! You must do better! You've lost the trust of the American people Time to start putting the brakes on this thing now that the election is almost here. take with a glass of Clorax
Source: cnnbrk - 🏆 393. / 55 Read more »